Gene G Olinger

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Respiratory Syndrome Coronavirus

Drug Administration

Top Venues

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Courtney L Finch, Julie Dyall, Shuang Xu, Elizabeth A Nelson, Elena Postnikova, Janie Y Liang, Huanying Zhou, Lisa Evans DeWald, Craig J Thomas, Amy Wang, Xin Xu, Emma Hughes, Patrick J Morris, Jon C Mirsalis, Linh H Nguyen, Maria P Arolfo, Bryan Koci, Michael R Holbrook, Lisa E Hensley, Peter B Jahrling, Connie Schmaljohn, Lisa M Johansen, Gene G Olinger, Joshua T Schiffer, Judith M White
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo. Microorganisms 9 (3) (2021)
Anna M Bruchez, Ky Sha, Joshua C Johnson, Li Chen, Caroline Stefani, Hannah McConnell, Lea Gaucherand, Rachel Prins, Kenneth A Matreyek, Adam J Hume, Elke Mühlberger, Emmett V Schmidt, Gene G Olinger, Lynda M Stuart, Adam Lacy-Hulbert
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science (New York, N.Y.) 370 (6513) (2020)